Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
2001 1
2002 8
2003 11
2004 7
2005 12
2006 10
2007 8
2008 9
2009 6
2010 5
2011 12
2012 12
2013 12
2014 9
2015 11
2016 8
2017 8
2018 11
2019 7
2020 7
2021 7
2022 11
2023 11
2024 2
2025 12
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
[Deciduoid Mesothelioma].
Nishikawa T, Takahashi M, Mori M, Kamikawa Y, Fujii C, Inoue F. Nishikawa T, et al. Among authors: takahashi m. Kyobu Geka. 2016 Mar;69(3):214-7. Kyobu Geka. 2016. PMID: 27075289 Japanese.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
SIRT1 Expression Is a Promising Prognostic Biomarker in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Otsuka R, Sakata H, Murakami K, Kano M, Endo S, Toyozumi T, Matsumoto Y, Suito H, Takahashi M, Sekino N, Hirasawa S, Kinoshita K, Sasaki T, Matsubara H. Otsuka R, et al. Among authors: takahashi m. Cancer Diagn Progn. 2022 Mar 3;2(2):126-133. doi: 10.21873/cdp.10086. eCollection 2022 Mar-Apr. Cancer Diagn Progn. 2022. PMID: 35399170 Free PMC article. Review.
198 results